NYKODE THERAPEUTICS ASA (NYKD.OL) Stock Cash Flow
Europe - Euronext Oslo - OSL:NYKD - NO0010714785 - Common Stock
2.594 NOK
+0.13 (+5.11%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -16.64M | -45.51M | -44.09M | -50.98M | -11.12M | |||
| Depreciation Amortization | 2.08M | 2.25M | 2.12M | 1.81M | 734.00K | |||
| Change In Working Capital | -11.19M | -9.15M | -44.85M | 30.79M | -7.82M | |||
| Interest Paid | 131.00K | 179.00K | 215.00K | 240.00K | 130.00K | |||
| Other non cash items | -9.94M | 1.19M | -9.81M | -2.32M | 19.36M | |||
| OPERATING CASH FLOW | -35.28M | -51.22M | -96.62M | -20.69M | 1.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -88.00K | -71.00K | -1.90M | -2.67M | -872.00K | |||
| Other Investing Activity | 4.70M | 7.00M | 8.94M | 13.72M | 11.63M | |||
| INVESTING CASH FLOW | 4.62M | 6.93M | 7.04M | 11.05M | 10.75M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.35M | -1.22M | -893.00K | -1.20M | -611.00K | |||
| Stock Issued/Repurchased | N/A | 0.00 | 45.70M | 1.80M | 21.18M | |||
| Other Financing Activity | -131.00K | -179.00K | -215.00K | -240.00K | -131.00K | |||
| FINANCING CASH FLOW | -33.76M | -1.40M | 44.59M | 360.00K | 20.44M | |||
| Exchange Rate Effect | 4.14M | -1.51M | 1.21M | -560.00K | 30.00K | |||
| CHANGE IN CASH | -60.29M | -47.20M | -43.78M | -9.84M | 32.38M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -35.28M | -51.22M | -96.62M | -20.69M | 1.16M | |||
| Capital Expenditure | -88.00K | -71.00K | -1.90M | -2.67M | -872.00K | |||
| FREE CASH FLOW | -35.37M | -51.29M | -98.53M | -23.37M | 284.00K | |||
All data in USD (non-GAAP EPS in NOK )